Association between genetic predisposition and disease burden of stroke in China: a genetic epidemiological study.
China
Disease burden
Genetic risk
Geographical variation
Stroke
Journal
The Lancet regional health. Western Pacific
ISSN: 2666-6065
Titre abrégé: Lancet Reg Health West Pac
Pays: England
ID NLM: 101774968
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
08
02
2023
revised:
31
03
2023
accepted:
17
04
2023
medline:
7
8
2023
pubmed:
7
8
2023
entrez:
7
8
2023
Statut:
epublish
Résumé
Stroke ranks second worldwide and first in China as a leading cause of death and disability. It has a polygenic architecture and is influenced by environmental and lifestyle factors. However, it remains unknown as to whether and how much the genetic predisposition of stroke is associated with disease burden. Allele frequency from the whole genome sequencing data in the Chinese Millionome Database of 141,418 individuals and trait-specific polygenic risk score models were applied to estimate the provincial genetic predisposition to stroke, stroke-related risk factors and stroke-related drug response. Disease burden including mortality, disability-adjusted life years (DALYs), years of life lost(YLLs), years lived with disability (YLDs) and prevalence in China was collected from the Global Burden Disease study. The association between stroke genetic predisposition and the epidemiological burden was assessed and then quantified in both regression-based models and machine learning-based models at a provincial resolution. Among the 30 administrative divisions in China, the genetic predisposition of stroke was characterized by a north-higher-than-south gradient (p < 0.0001). Genetic predisposition to stroke, blood pressure, body mass index, and alcohol use were strongly intercorrelated (rho >0.6; p < 0.05 after Bonferroni correction for each comparison). Genetic risk imposed an independent effect of approximately 1-6% on mortality, DALYs and YLLs. The distribution pattern of stroke genetic predisposition is different at a macroscopic level, and it subtly but significantly impacts the epidemiological burden. Further research is warranted to identify the detailed aetiology and potential translation into public health measures. Beijing Municipal Science and Technology Commission (Z191100006619106), CAMS Innovation Fund for Medical Sciences (CAMS-I2M, 2023-I2M-1-001), the National High Level Hospital Clinical Research Funding (2022-GSP-GG-17), National Natural Science Foundation of China (32000398, 32171441 to X.J.), Natural Science Foundation of Guangdong Province, China (2017A030306026 to X.J.), and National Key R&D Program of China (2022YFC2502402).
Sections du résumé
Background
UNASSIGNED
Stroke ranks second worldwide and first in China as a leading cause of death and disability. It has a polygenic architecture and is influenced by environmental and lifestyle factors. However, it remains unknown as to whether and how much the genetic predisposition of stroke is associated with disease burden.
Methods
UNASSIGNED
Allele frequency from the whole genome sequencing data in the Chinese Millionome Database of 141,418 individuals and trait-specific polygenic risk score models were applied to estimate the provincial genetic predisposition to stroke, stroke-related risk factors and stroke-related drug response. Disease burden including mortality, disability-adjusted life years (DALYs), years of life lost(YLLs), years lived with disability (YLDs) and prevalence in China was collected from the Global Burden Disease study. The association between stroke genetic predisposition and the epidemiological burden was assessed and then quantified in both regression-based models and machine learning-based models at a provincial resolution.
Findings
UNASSIGNED
Among the 30 administrative divisions in China, the genetic predisposition of stroke was characterized by a north-higher-than-south gradient (p < 0.0001). Genetic predisposition to stroke, blood pressure, body mass index, and alcohol use were strongly intercorrelated (rho >0.6; p < 0.05 after Bonferroni correction for each comparison). Genetic risk imposed an independent effect of approximately 1-6% on mortality, DALYs and YLLs.
Interpretation
UNASSIGNED
The distribution pattern of stroke genetic predisposition is different at a macroscopic level, and it subtly but significantly impacts the epidemiological burden. Further research is warranted to identify the detailed aetiology and potential translation into public health measures.
Funding
UNASSIGNED
Beijing Municipal Science and Technology Commission (Z191100006619106), CAMS Innovation Fund for Medical Sciences (CAMS-I2M, 2023-I2M-1-001), the National High Level Hospital Clinical Research Funding (2022-GSP-GG-17), National Natural Science Foundation of China (32000398, 32171441 to X.J.), Natural Science Foundation of Guangdong Province, China (2017A030306026 to X.J.), and National Key R&D Program of China (2022YFC2502402).
Identifiants
pubmed: 37547044
doi: 10.1016/j.lanwpc.2023.100779
pii: S2666-6065(23)00097-4
pmc: PMC10398595
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100779Informations de copyright
© 2023 The Author(s).
Déclaration de conflit d'intérêts
We declare no competing interests.
Références
Clin Pharmacol Ther. 2022 May;111(5):1007-1021
pubmed: 35152405
Hum Mol Genet. 2016 Dec 15;25(24):5472-5482
pubmed: 27702941
Nucleic Acids Res. 2023 Jan 6;51(D1):D890-D895
pubmed: 35871305
Lancet Public Health. 2022 Jan;7(1):e74-e85
pubmed: 34756176
N Engl J Med. 2020 Jul 23;383(4):369-378
pubmed: 32706535
Nature. 2022 Nov;611(7934):115-123
pubmed: 36180795
Nature. 2020 May;581(7809):434-443
pubmed: 32461654
Int J Stroke. 2022 Oct;17(9):946-956
pubmed: 35975986
Clin Pharmacol Ther. 2022 Nov;112(5):959-967
pubmed: 35034351
Circ Res. 2022 Apr 15;130(8):1095-1111
pubmed: 35420914
Circulation. 2022 Aug 23;146(8):e93-e118
pubmed: 35862132
Circulation. 2021 Feb 2;143(5):470-478
pubmed: 33185476
Hereditas. 2020 Dec 8;157(1):49
pubmed: 33292737
JAMA Intern Med. 2018 Aug 1;178(8):1086-1097
pubmed: 29971434
Circulation. 2017 Feb 21;135(8):759-771
pubmed: 28052979
Atherosclerosis. 2014 Aug;235(2):463-9
pubmed: 24950001
Am J Clin Nutr. 2022 Aug 4;116(2):386-393
pubmed: 35551603
Neurology. 2021 Aug 10;97(6):e619-e628
pubmed: 34031205
Lancet Neurol. 2016 Feb;15(2):174-184
pubmed: 26708676
Cell. 2018 Oct 4;175(2):347-359.e14
pubmed: 30290141
Am J Clin Nutr. 2022 Sep 2;116(3):771-779
pubmed: 35687413
Lancet Public Health. 2021 Dec;6(12):e897-e906
pubmed: 34838196
Int J Stroke. 2022 Jan;17(1):18-29
pubmed: 34986727
Eur Heart J Cardiovasc Pharmacother. 2022 Sep 29;8(7):738-751
pubmed: 35848895
Stroke. 2013 Jul;44(7):1775-83
pubmed: 23674531
Stroke. 1995 Dec;26(12):2222-7
pubmed: 7491640
Sci Rep. 2019 Nov 22;9(1):17330
pubmed: 31758035
Clin Pharmacol Ther. 2017 Sep;102(3):397-404
pubmed: 28198005
Stroke. 2013 Jun;44(6):1717-9
pubmed: 23640828
JAMA Cardiol. 2019 Apr 1;4(4):342-352
pubmed: 30865215
Circ Genom Precis Med. 2021 Jun;14(3):e003168
pubmed: 34029116
Stroke. 2002 Mar;33(3):769-74
pubmed: 11872902
BMC Med. 2018 Jul 10;16(1):104
pubmed: 29986700
Nat Genet. 2018 Apr;50(4):524-537
pubmed: 29531354
Eur Heart J. 2022 May 7;43(18):1702-1711
pubmed: 35195259
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Lancet Neurol. 2021 Oct;20(10):795-820
pubmed: 34487721
Lancet Neurol. 2016 Jun;15(7):695-707
pubmed: 27068588
BMC Med. 2017 Jul 11;15(1):132
pubmed: 28693510